科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02171 科济药业-B

未开盘 12-16 16:08:20

14.880

-0.450

-2.94%

最高15.330	最低14.000	成交量342.00万
今开15.330	昨收15.330	日振幅8.68%
总市值85.11亿	流通市值85.11亿	总股本5.72亿
成交额4,992万	换手率0.60%	流通股本5.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科济药业-B","latestPrice":14.88,"timestamp":1765872500005,"preClose":15.33,"halted":0,"volume":3420003,"delay":0,"floatShares":572000000,"shares":572000000,"eps":-1.5965790935455515,"marketStatus":"未开盘","change":-0.45,"latestTime":"12-16 16:08:20","open":15.33,"high":15.33,"low":14,"amount":49917348,"amplitude":0.086758,"askPrice":14.88,"askSize":13000,"bidPrice":14.8,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-1.0496729877943476,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":0,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.33,"openAndCloseTimeList":[[1765848600000,1765857600000],[1765861200000,1765872000000]],"volumeRatio":1.533422,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171/tweets","defaultTab":"tweets","newsList":[{"id":"2591987462","title":"科济药业-B(02171)12月16日斥资1476.2万港元回购101万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591987462","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591987462?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:49","pubTimestamp":1765892991,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B(02171)发布公告，于2025年12月16日斥资1476.2万港元回购101万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1587","BK1161","BK1574","02171"],"gpt_icon":0},{"id":"2591998813","title":"每日卖空追踪 | 科济药业-B 12月16日卖空量成交8.7万股，卖空比例为2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591998813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591998813?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873826,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月16日，跌2.94%，卖空量成交8.7万股，较上一交易日减少70.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163408a6a8b60b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163408a6a8b60b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1587","BK1585","BK1574","BK1161"],"gpt_icon":0},{"id":"2591459856","title":"科济药业-B(02171)12月15日斥资790.76万港元回购52.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591459856","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591459856?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:00","pubTimestamp":1765800031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B(02171)发布公告，于2025年12月15日斥资790.76万港元回购52.2万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02171","BK1585","BK1574","BK1161"],"gpt_icon":0},{"id":"2590703505","title":"科济药业-B(02171)12月12日斥资389.45万港元回购25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590703505","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590703505?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:15","pubTimestamp":1765541718,"startTime":"0","endTime":"0","summary":"科济药业-B(02171)发布公告，于2025年12月12日斥资389.45万港元回购25万股。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_25.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_25.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1587","BK1585","BK1161","02171","BK1574"],"gpt_icon":0},{"id":"2590523879","title":"智通港股回购统计|12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590523879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590523879?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:10","pubTimestamp":1765501802,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量105.40 万，回购金额6.36 亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01458","02866","02273","03798","01907","01681","02416","09886","09896","00386","01919","06098","01810","02347","00345","02018","02392","02219","02039","02367","09959","00175","02369","00909","00947","01024","01588","06186","02869","01382","01951","08188","00383","02171","06868","02419","02517","00732","01066","02886","03888","00799","01317","06826","02319","00434","00700","09878","02158","09869"],"gpt_icon":1},{"id":"2590526995","title":"mPFS 50.4个月，ORR 100%：多发性骨髓瘤CAR-T之争","url":"https://stock-news.laohu8.com/highlight/detail?id=2590526995","media":"研发客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590526995?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:00","pubTimestamp":1765486842,"startTime":"0","endTime":"0","summary":"// 2025 ASH年会上，CAR-T治疗多发性骨髓瘤研究的摘要有140多个； 体内CAR-T疗法在复发难治性多发性骨髓瘤患者中MRD阴性率100%，三个月内均保持MRD阴性反应，5个月随访期内所有患者均保持应答状态； 科济、瓴路、驯鹿这些中国本土CAR-T公司的产品也崭露头角。此次在大会上公布的是 KLN-1010在Ⅰ期 inMMyCAR 研究中的首次人体试验结果。截至目前，所有观察三个月的患者均表现出持久记忆性 CAR-T 效应。事实上，KLN-1010并非首款在R/R MM患者中证明初步疗效的体内CAR-T。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212050219a4432679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212050219a4432679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02171","BK1587","BK1585","BK1161"],"gpt_icon":0},{"id":"2590552513","title":"科济药业-B(02171)12月11日耗资约1588.62万港元回购102万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590552513","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590552513?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:13","pubTimestamp":1765455213,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B(02171)公布，2025年12月11日耗资约1588.62万港元回购102万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1585","BK1161","02171","BK1574"],"gpt_icon":0},{"id":"2590202597","title":"非执行董事郭华清减持科济药业(02171)1万股 每股作价17.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590202597","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590202597?lang=zh_cn&edition=full","pubTime":"2025-12-11 18:53","pubTimestamp":1765450414,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，12月8日，非执行董事郭华清减持科济药业(02171)1万股，每股作价17.7港元，总金额为17.7万港元。减持后最新持股数目约为2.18亿股，持股比例为37.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1161","02171","BK1574","BK1585"],"gpt_icon":0},{"id":"2590526912","title":"科济药业-B股价大跌5.00% CAR-T产品赛恺泽®纳入商保创新药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2590526912","media":"港美通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590526912?lang=zh_cn&edition=full","pubTime":"2025-12-11 10:57","pubTimestamp":1765421872,"startTime":"0","endTime":"0","summary":"12月11日10:38，科济药业-B(02171)股价大幅下跌5.00%。该股报16.150港元，最高报17.070港元，最低报16.150港元，成交量83.05万股，成交额1374.13万港元。科济药业近日宣布其自主研发的全人源BCMA靶向CAR-T产品赛恺泽®被纳入《商业健康保险创新药品目录（2025年）》，用于治疗复发/难治性多发性骨髓瘤。科济药业是一家生物制药公司，专注于开发创新CAR-T细胞疗法，以满足未满足的临床需求，包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。公司形成了从靶点发现、临床前研究、产品临床开发到商业规模生产的CAR-T细胞研究与开发的端到端能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211110015a441616f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211110015a441616f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1587","BK1574","BK1161","BK1585","02171"],"gpt_icon":0},{"id":"2590339805","title":"每日卖空追踪 | 科济药业-B 12月10日卖空量成交7.5万股，卖空比例为5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590339805","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590339805?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355428,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月10日，跌1.73%，卖空量成交7.5万股，较上一交易日减少55.36%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016341695353d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016341695353d0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1574","BK1585","BK1587","BK1161"],"gpt_icon":0},{"id":"1184256052","title":"科济药业-B公布2025年ASH年会上关于异基因Bcma CAR-T细胞疗法Ct0596在复发/难治性多发性骨髓瘤的数据显示","url":"https://stock-news.laohu8.com/highlight/detail?id=1184256052","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184256052?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:17","pubTimestamp":1765153051,"startTime":"0","endTime":"0","summary":"科济药业-B公布2025年ASH年会上关于异基因Bcma CAR-T细胞疗法Ct0596在复发/难治性多发性骨髓瘤的数据显示","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1587","BK1161","BK1574","BK1585"],"gpt_icon":0},{"id":"2589804895","title":"科济药业-B(02171)：CT0596的初步结果已在第67届美国血液学会年会上进行报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2589804895","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589804895?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:09","pubTimestamp":1765152595,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B 发布公告，CT0596的初步结果已在第67届美国血液学会年会上进行报告。CT0596是一款靶向BCMA的通用型CAR-T细胞疗法，基于科济药业自主研发的 THANK-u Plus平台开发，目前正在复发╱难治性多发性骨髓瘤或浆细胞白血病中开展研究者发起的临床试验。CT0596显示出初步良好的安全性及令人鼓舞的疗效信号，在所有预设剂量组均观察到CAR-T细胞的扩增。本公司预估2025年下半年提交该品种的IND申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科济药业-B(02171)：CT0596的初步结果已在第67届美国血液学会年会上进行报告","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK1587","BK1585","02171"],"gpt_icon":0},{"id":"2589039807","title":"2025国谈落地：双管齐下 从“用得上”走向“用得起”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589039807","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589039807?lang=zh_cn&edition=full","pubTime":"2025-12-08 00:09","pubTimestamp":1765123740,"startTime":"0","endTime":"0","summary":"2026年1月1日起，中国医保目录将迎来历史上规模最大的一次创新药扩容。新版医保目录将于2026年1月1日起正式实施。当创新药从“临床可用”迈向“医保可及”，一场深刻的产业变革正在悄然发生。诺华共有2个新产品及4个新适应症成功纳入2025年版国家医保药品目录。此次阿斯利康康可期纳入2025年国家医保目录，助力血液肿瘤患者“活得更长、活得更好”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120807455197953c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120807455197953c25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02171","06978","JNJ","02196","BK1585","BK1161"],"gpt_icon":0},{"id":"2589877119","title":"19种药品纳入首版商保目录，5款CAR-T疗法集体入围，影响有多大？","url":"https://stock-news.laohu8.com/highlight/detail?id=2589877119","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589877119?lang=zh_cn&edition=full","pubTime":"2025-12-07 21:37","pubTimestamp":1765114670,"startTime":"0","endTime":"0","summary":"在7日的大会现场，国家医保局相关负责人还为入选商保创新药目录的企业代表颁发了证书。根据此前公布的数据，首版商保创新药目录申报信息共有141份，涉及药品通用名141个，121个通过形式审查，实际参与商保创新药目录价格协商的药品24个。进入商保目录后，公司CAR-T疗法的对外价格还是不变的，但对于保险公司会有一个折扣价格。两款药物均出现在首版目录名单，有望造福更多AD患者。从最终的结果来看，该产品未能进入商保目录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207213959a439684c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207213959a439684c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","06160","LU0154236417.USD","BK4585","02171","01228","BK4022","02161","BK4532","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4230","LU1093756168.USD","NVO","BK4007","BK4588","BK4599","688235","LU1093756325.SGD","ONC"],"gpt_icon":0},{"id":"2588887605","title":"“抗癌神药”屡登热搜，CAR-T如何从绝症救星走向百万患者？","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887605","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588887605?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:29","pubTimestamp":1764840543,"startTime":"0","endTime":"0","summary":"国内已上市的CAR-T疗法价格普遍在百万元左右。近期，价格高达百万的“抗癌针”屡屡登上热搜榜单。CAR-T细胞治疗产品凭借其独特的作用机制，能为患者带来可预见的治愈效果。经过多方咨询与考量，他们最终决定前往中国上海的曜影医院接受CAR-T治疗。上述分析师指出，全球CAR-T市场已形成“中美双强”的格局。2025年9月，中国科学技术大学团队针对系统性红斑狼疮的CAR-T疗法临床研究取得关键进展。连续四年，多款CAR-T产品冲刺国家医保目录均铩羽而归。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204173955952a98ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204173955952a98ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","02126","02171","BK1574"],"gpt_icon":0},{"id":"2589859301","title":"每日卖空追踪 | 科济药业-B 12月04日卖空量成交3.35万股，卖空比例为2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589859301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589859301?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837029,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月04日，涨6.85%，卖空量成交3.35万股，较上一交易日减少91.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163429952a7bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163429952a7bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1587","BK1161","BK1574","BK1585"],"gpt_icon":0},{"id":"2588397690","title":"每日卖空追踪 | 科济药业-B 12月02日卖空量成交6.9万股，卖空比例为9.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588397690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588397690?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664226,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月02日，涨0.18%，卖空量成交6.9万股，较上一交易日减少6.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163350a4c79f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163350a4c79f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","BK1585","02171"],"gpt_icon":0},{"id":"1125776442","title":"科濟藥業控股（02171）回购17.35万股股份，总额约296万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125776442","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125776442?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:50","pubTimestamp":1764597043,"startTime":"0","endTime":"0","summary":"科濟藥業控股有限公司于2025年12月1日公布翌日披露报表，显示当日通过联交所场内回购173,500股普通股，占回购前公司已发行股本约0.03%。回购价区间介乎每股17.05港元至17.16港元，总金额约296万港元。回购完成后，公司已发行股份数量减至574,069,155股，库存股则增至3,904,000股，合计总股本仍为577,973,155股。公司股东大会已于2025年5月22日通过股份回购授权，授权可回购总数为57,543,590股，截至目前累计回购4,359,000股，占授权时已发行股本约0.758%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"2588782007","title":"科济药业-B(02171)12月1日耗资约296.395万港元回购17.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588782007","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588782007?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:44","pubTimestamp":1764596668,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B(02171)公布，2025年12月1日耗资约296.395万港元回购17.35万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02171","BK1585","BK1161","BK1574"],"gpt_icon":0},{"id":"2588081700","title":"科济药业-B12月01日主力净流出9.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588081700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588081700?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576939,"startTime":"0","endTime":"0","summary":"12月01日, 科济药业-B股价跌1.90%，报收17.06元，成交金额1772.0万元，换手率0.18%，振幅5.52%，量比0.30。科济药业-B今日主力资金净流出9.8万元，上一交易日主力净流入88.0万元。该股近5个交易日上涨9.26%，主力资金累计净流入246.1万元；近20日主力资金累计净流入443.4万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161825a71c673d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161825a71c673d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":-0.1399},{"period":"1month","weight":-0.1683},{"period":"3month","weight":-0.2867},{"period":"6month","weight":-0.3839},{"period":"1year","weight":0.542},{"period":"ytd","weight":0.6156}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0679},{"period":"3month","weight":-0.0622},{"period":"6month","weight":0.086},{"period":"1year","weight":0.2748},{"period":"ytd","weight":0.258}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是从事开发嵌合抗原受体T细胞（CAR-T）细胞疗法，以满足临床需求，包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽（泽沃基奥仑赛注射液）、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.109168},{"month":2,"riseRate":0.75,"avgChangeRate":0.310052},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058137}],"exchange":"SEHK","name":"科济药业-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科济药业-B,02171,科济药业-B股票,科济药业-B股票老虎,科济药业-B股票老虎国际,科济药业-B行情,科济药业-B股票行情,科济药业-B股价,科济药业-B股市,科济药业-B股票价格,科济药业-B股票交易,科济药业-B股票购买,科济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}